GSK Plc (GSK)

59.50 +0.24 (+0.40%) USD  |  NYSE  |  Feb 24, 11:41
More

GSK Change in Payables and Accrued Expense (Quarterly)

Change in Payables and Accrued Expense (Quarterly) Chart

View Change in Payables and Accrued Expense (Quarterly) for GSK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Change in Payables and Accrued Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years

View Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Change in Payables and Accrued Expense (Quarterly) Benchmarks

View Change in Payables and Accrued Expense (Quarterly) Benchmarks
Start Trial
AstraZeneca PLC --
Mereo BioPharma Group Plc Upgrade
Novavax, Inc. Upgrade
Biodexa Pharmaceuticals Plc --
AnaptysBio, Inc. Upgrade